SMARCA4 and Salla disease: In this study, we retrospectively analyzed the clinicopathological data of three cases of SMARCA4-deficient large cell neuroendocrine carcinoma (SD-LCNEC), reporting for the first time the distinct features of this rare and aggressive subtype characterized by early metastasis and reduced expression of neuroendocrine markers.